Skip to content

Clinical trials

Recruiting Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Status: Recruiting Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20171
20192
20202
20221
20233
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Princess Maxima Center for Pediatric Oncology4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Charite University, Berlin, Germany1
Incyte Biosciences International Sàrl1
Mats Heyman1
Matthijs de Hoog1
Pfizer1
St. Anna Kinderkrebsforschung1
Syndax Pharmaceuticals1
University Hospital Muenster1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Leukemia7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma3
Recurrence3
Leukemia, Biphenotypic, Acute2
Leukemia, Myeloid, Acute2
Blast Crisis1
Heart Arrest1
Leukemia, Myeloid, Accelerated Phase1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.